Latest Financials News

Anatara Lifesciences has received nearly $1 million from the Australian Government’s R&D tax incentive, providing a vital capital injection to advance its Anti-Obesity pre-clinical studies.

Arovella Therapeutics reported a robust $20.9 million cash position as it prepares for its first-in-human trial of ALA-101 and expands its solid tumour pipeline through new licensing agreements and leadership appointments.

Bubs Australia has appointed Joe Coote as its new CEO, bringing extensive international FMCG and dairy leadership to spearhead its global growth ambitions in infant nutrition.

Moab Minerals is progressing its Manyoni uranium project with a planned JORC-compliant resource estimate and is nearing completion of a key tenement acquisition, while securing fresh funding to support ongoing exploration.

International Graphite Limited (ASX – IG6) has had its trading suspension lifted following the announcement of a new agreement to develop a graphite processing facility in Europe.

International Graphite Limited has partnered with Arctic Graphite AS to establish a new expandable graphite facility in Germany, aiming to bolster European supply with an initial 3,000 tonnes per year capacity. Backed by a potential $10 million funding commitment, this venture marks a strategic push into critical mineral processing amid rising demand.

Comet Resources has sold a significant stake in International Graphite, using part of the proceeds to clear its debt, triggering a board resignation and signaling a shift in shareholder dynamics.

Peninsula Energy has completed a major reset of its uranium offtake contracts, terminating five of six agreements with a $6.6 million payout, while advancing commissioning of its Central Processing Plant toward first yellowcake production in Q3 2025.

Larvotto Resources has opened a $5 million Share Purchase Plan offering shares at a 13.5% discount to fund key development and exploration activities at its Hillgrove Project in NSW.

Anax Metals has raised $3.3 million through convertible notes to push forward its Whim Creek copper-zinc project in Western Australia, while resolving a recent arbitration with its cornerstone investor Mineral Development Partners.

Emyria has secured a landmark multi-year funding agreement with Medibank to reimburse PTSD patients under its Empax program, alongside opening a second clinic and reporting durable clinical improvements in treatment-resistant PTSD cases.

Bubs Australia Limited reports a strong FY25 with 29% revenue growth to $102.5 million, positive EBITDA turnaround, and sustained cash flow improvements. The company also advances its US market ambitions with a key FDA submission underway.